{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T02:34:45Z","timestamp":1781231685850,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019R1A2C1006194"],"award-info":[{"award-number":["2019R1A2C1006194"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Airway remodeling is an important pathological feature of chronic airway diseases, which leads to a progressive decline in lung function. The present study examined the anti-remodeling and anti- inflammatory effect of BIBF1000, a triple-tyrosine kinase inhibitor that targets VEGF, PDGF, and FGF receptor signaling in a mouse model of repeated ovalbumin (OVA) challenges.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Female Balb-c mice were immunized intraperitoneally on days 0 and 12 with 50\u00a0\u00b5g ovalbumin plus 1\u00a0mg of Al(OH)3 in 200 \u03bcl saline. Intranasal OVA challenges (20\u00a0\u00b5g\/50\u00a0\u00b5l in PBS) were administered on days 26, 29, and 31, and were repeated twice a week for 3\u00a0months. Animals received vehicle or BIBF1000 (25\u00a0mg\/kg, b.i.d.) through gavage from day 26 to the end of fourth month. On day 120, bronchoalveolar lavage (BAL) and lung tissue were collected for biochemical and immunohistological analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Compared to vehicle controls, treatment with BIBF1000 reduced the numbers of BAL eosinophils, macrophages, neutrophils, and lymphocytes by 70.0%, 57.9%, 47.5%, and 63.0%, respectively, and reduced IL-5 and IL-13 in BAL. Treatment with BIBF1000 reduced airway mucus secretion, peribronchial fibrosis, small airway, and pulmonary arterial wall thickness, compared to vehicle controls. Furthermore, treatment with BIBF1000 also reduced the expression of inflammatory mediators (TNF-\u03b1, IL-1\u03b2, IL-5, IL-13, MMP-2, MMP-9, COX-2, and iNOS) and inhibited ERK and AKT phosphorylation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The protective effect afforded by triple-tyrosine kinase inhibition with BIBF1000 in reducing allergen-induced airway and arterial remodeling was associated with down-regulation of inflammatory mediators, as well as inhibition of ERK and AKT signaling pathways.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-023-01037-2","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T03:02:56Z","timestamp":1675911776000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Triple-tyrosine kinase inhibition by BIBF1000 attenuates airway and pulmonary arterial remodeling following chronic allergen challenges in mice"],"prefix":"10.1186","volume":"28","author":[{"given":"Malarvizhi","family":"Gurusamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Nasseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dileep Reddy","family":"Rampa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Pekcec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Doods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,9]]},"reference":[{"key":"1037_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1385\/CRIAI:27:1:001","volume":"27","author":"T Nakagawa","year":"2004","unstructured":"Nakagawa T, Hoshino M. Airway remodeling in asthma: an introduction. Clin Rev Allergy Immunol. 2004;27:1\u20132.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1037_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.physiol.59.1.89","volume":"59","author":"KR Stenmark","year":"1997","unstructured":"Stenmark KR, Mecham RP. Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu Rev Physiol. 1997;59:89\u2013144.","journal-title":"Annu Rev Physiol"},{"issue":"4","key":"1037_CR3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2332\/allergolint.R-07-152","volume":"56","author":"E Tagaya","year":"2007","unstructured":"Tagaya E, Tamaoki J. Mechanisms of airway remodeling in asthma. Allergol Int. 2007;56(4):331\u201340.","journal-title":"Allergol Int"},{"key":"1037_CR4","first-page":"3395","volume":"186","author":"YC Lee","year":"2002","unstructured":"Lee YC, Kwak Y-G, Song CH. Contribution of vascular endothelial growth factor hyperresponsivor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J Immunol. 2002;186:3395\u2013600.","journal-title":"J Immunol"},{"issue":"8","key":"1037_CR5","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1172\/JCI8124","volume":"104","author":"JA Elias","year":"1999","unstructured":"Elias JA, Zhu Z, Chupp G, Homer RJ. Airway remodeling in asthma. J Clin Invest. 1999;104(8):1001\u20136.","journal-title":"J Clin Invest"},{"issue":"6","key":"1037_CR6","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.jaci.2007.10.025","volume":"120","author":"ST Holgate","year":"2007","unstructured":"Holgate ST. Epithelium dysfunction in asthma. J Allergy Clin Immunol. 2007;120(6):1233\u201344.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1037_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/thx.53.1.21","volume":"53","author":"M Hoshino","year":"1998","unstructured":"Hoshino M, Nakamura Y, Sim JJ. Expression of growth factors and remodelling of the airway wall in bronchial asthma. Thorax. 1998;53(1):21\u20137.","journal-title":"Thorax"},{"issue":"5","key":"1037_CR8","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1183\/09031936.00152106","volume":"29","author":"NI Chaudhary","year":"2007","unstructured":"Chaudhary NI, Roth GJ, Hilberg F, M\u00fcller-Quernheim J, Prasse A, Zissel G, Schnapp A, Park JE. Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis. Eur Respir J. 2007;29(5):976\u201385.","journal-title":"Eur Respir J"},{"issue":"4","key":"1037_CR9","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1365-2222.2004.1917.x","volume":"34","author":"RK Kumar","year":"2004","unstructured":"Kumar RK, Herbert C, Foster PS. Expression of growth factors by airway epithelial cells in a model of chronic asthma: regulation and relationship to subepithelial fibrosis. Clin Exp Allergy. 2004;34(4):567\u201375.","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"1037_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3892\/etm.2014.1759","volume":"8","author":"H Zou","year":"2014","unstructured":"Zou H, Fang QH, Ma YM, Wang XY. Analysis of growth factors in serum and induced sputum from patients with asthma. Exp Ther Med. 2014;8(2):573\u20138.","journal-title":"Exp Ther Med"},{"issue":"2","key":"1037_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12094-006-0162-1","volume":"8","author":"R Perona","year":"2006","unstructured":"Perona R. Cell signalling: growth factors and tyrosine kinase receptors. Clin Transl Oncol. 2006;8(2):77\u201382.","journal-title":"Clin Transl Oncol"},{"key":"1037_CR12","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1067\/mai.2001.115626","volume":"107","author":"M Hoshino","year":"2001","unstructured":"Hoshino M, Nakamura Y, Hamid QA. Gene expression of vascular endothelial growth factor and receptors and angiogenesis in bronchial asthma. J Allergy Clin Immunol. 2001;107:1034\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1037_CR13","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1165\/rcmb.2005-0309OC","volume":"34","author":"Y Boss\u00e9","year":"2006","unstructured":"Boss\u00e9 Y, Thompson C, Stankova J, Rola-Pleszczynski M. Fibroblast growth factor 2 and transforming growth factor beta1 synergism in human bronchial smooth muscle cell proliferation. Am J Respir Cell Mol Biol. 2006;34(6):746\u201353.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1037_CR14","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2174\/156652406777435426","volume":"6","author":"JL Ingram","year":"2006","unstructured":"Ingram JL, Bonner JC. EGF and PDGF receptor tyrosine kinases as therapeutic targets for chronic lung diseases. Curr Mol Med. 2006;6:409\u201321.","journal-title":"Curr Mol Med"},{"issue":"3","key":"1037_CR15","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.jaci.2004.11.051","volume":"115","author":"CC Lewis","year":"2005","unstructured":"Lewis CC, Chu HW, Westcott JY, Tucker A, Langmack EL, Sutherland ER, Kraft M. Airway fibroblasts exhibit a synthetic phenotype in severe asthma. J Allergy Clin Immunol. 2005;115(3):534\u201340.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1037_CR16","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1165\/rcmb.2010-0277OC","volume":"45","author":"JA Hirota","year":"2011","unstructured":"Hirota JA, Ask K, Farkas L, Smith JA, Ellis R, Rodriguez-Lecompte JC, Kolb M, Inman MD. In vivo role of platelet-derived growth factor-BB in airway smooth muscle proliferation in mouse lung. Am J Respir Cell Mol Biol. 2011;45(3):566\u201372.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"1037_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000317213","volume":"155","author":"HY Yum","year":"2011","unstructured":"Yum HY, Cho JY, Miller M, Broide DH. Allergen-induced coexpression of bFGF and TGF-\u03b21 by macrophages in a mouse model of airway remodeling: bFGF induces macrophage TGF-\u03b21 expression in vitro. Int Arch Allergy Immunol. 2011;155(1):12\u201322.","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"1037_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S2213-2600(16)00022-9","volume":"4","author":"S Laurenson","year":"2016","unstructured":"Laurenson S, Sidhu R, Goodall M, Adler AI. NICE guidance on nintedanib for treating idiopathic pulmonary fibrosis. Lancet Respir Med. 2016;4(3):176\u20137.","journal-title":"Lancet Respir Med"},{"issue":"4\u20135","key":"1037_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/01902148.2017.1339141","volume":"43","author":"HY Lee","year":"2017","unstructured":"Lee HY, Hur J, Kim IK, Kang JY, Yoon HK, Lee SY, Kwon SS, Kim YK, Rhee CK. Effect of nintedanib on airway inflammation and remodeling in a murine chronic asthma model. Exp Lung Res. 2017;43(4\u20135):187\u201396.","journal-title":"Exp Lung Res"},{"key":"1037_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.trsl.2018.07.010","volume":"203","author":"AS Ambade","year":"2019","unstructured":"Ambade AS, Jung B, Lee D, Doods H, Wu D. Triple-tyrosine kinase inhibition attenuates pulmonary arterial hypertension and neointimal formation. Transl Res. 2019;203:15\u201330.","journal-title":"Transl Res"},{"key":"1037_CR21","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/resp.12078","volume":"18","author":"M Takeda","year":"2013","unstructured":"Takeda M, Tanabe M, Ito W, Ueki S, Konnno Y, Chihara M, et al. Gender difference in allergic airway remodelling and immunoglobulin production in mouse model of asthma. Respirology. 2013;18:797\u2013806. https:\/\/doi.org\/10.1111\/resp.12078.","journal-title":"Respirology"},{"key":"1037_CR22","doi-asserted-by":"publisher","first-page":"875295","DOI":"10.3389\/falgy.2022.875295","volume":"3","author":"CD Ekpruke","year":"2022","unstructured":"Ekpruke CD, Silveyra P. Sex differences in airway remodeling and inflammation: clinical and biological factors. Front Allergy. 2022;3:875295.","journal-title":"Front Allergy"},{"key":"1037_CR23","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.phrs.2015.12.017","volume":"104","author":"M Gurusamy","year":"2016","unstructured":"Gurusamy M, Nasseri S, Lee H, Jung B, Lee D, Khang G, Abraham WM, Doods H, Wu D. Kinin B1 receptor antagonist BI113823 reduces allergen-induced airway inflammation and mucus secretion in mice. Pharmacol Res. 2016;104:132\u20139.","journal-title":"Pharmacol Res"},{"issue":"4","key":"1037_CR24","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1161\/HYPERTENSIONAHA.115.05338","volume":"66","author":"P Murugesan","year":"2015","unstructured":"Murugesan P, Hildebrandt T, Bernl\u00f6hr C, Lee D, Khang G, Doods H, Wu D. Inhibition of kinin B1 receptors attenuates pulmonary hypertension and vascular remodeling. Hypertension. 2015;66(4):906\u201312.","journal-title":"Hypertension"},{"issue":"6","key":"1037_CR25","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1513\/pats.201102-018MW","volume":"8","author":"CG Lee","year":"2011","unstructured":"Lee CG, Ma B, Takyar S, Ahangari F, Delacruz C, He CH, Elias JA. Studies of vascular endothelial growth factor in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2011;8(6):512\u20135.","journal-title":"Proc Am Thorac Soc"},{"issue":"11","key":"1037_CR26","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1136\/annrheumdis-2016-210823","volume":"76","author":"J Huang","year":"2017","unstructured":"Huang J, Maier C, Zhang Y, Soare A, Dees C, Beyer C, Harre U, Chen CW, Distler O, Schett G, Wollin L, Distler JHW. Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis. Ann Rheum Dis. 2017;76(11):1941\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1037_CR27","doi-asserted-by":"publisher","first-page":"00576","DOI":"10.1183\/23120541.00576-2021","volume":"8","author":"J Maspero","year":"2022","unstructured":"Maspero J, Adir Y, Al-Ahmad M, Celis-Preciado CA, Colodenco FD, Giavina-Bianchi P, et al. Type 2 inflammation in asthma and other airway diseases. ERJ Open Res. 2022;8(3):00576\u20132021.","journal-title":"ERJ Open Res"},{"key":"1037_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/rr40","volume":"2","author":"JW Steinke","year":"2001","unstructured":"Steinke JW, Borish L. Th2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir Res. 2001;2:66\u201370.","journal-title":"Respir Res"},{"key":"1037_CR29","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/S0140-6736(00)03496-6","volume":"356","author":"MJ Leckie","year":"2000","unstructured":"Leckie MJ, ten Brincke A, Khan J, Diamant Z, O\u2019Connor BJ, Walls CM, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness and the late asthmatic response. Lancet. 2000;356:2144\u20138.","journal-title":"Lancet"},{"issue":"6","key":"1037_CR30","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1165\/rcmb.2008-0053OC","volume":"39","author":"CG Lee","year":"2008","unstructured":"Lee CG, Hartl D, Matsuura H, Dunlop FM, Scotney PD, Fabri LJ, et al. Endogenous IL-11 signaling is essential in Th2- and IL-13-induced inflammation and mucus production. Am J Respir Cell Mol Biol. 2008;39(6):739\u201346.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"1037_CR31","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1378\/chest.101.4.916","volume":"101","author":"T Aikawa","year":"1992","unstructured":"Aikawa T, Shimura S, Sasaki H, Ebina M, Takishima T. Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest. 1992;101(4):916\u201321.","journal-title":"Chest"},{"issue":"3","key":"1037_CR32","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1164\/ajrccm.160.3.9902064","volume":"160","author":"W Busse","year":"1999","unstructured":"Busse W, Elias J, Sheppard D, Banks-Schlegel S. Airway remodeling and repair. Am J Respir Crit Care Med. 1999;160(3):1035\u201342.","journal-title":"Am J Respir Crit Care Med"},{"key":"1037_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1172\/JCI114436","volume":"85","author":"KB Adler","year":"1990","unstructured":"Adler KB, Holden-Stauffer WJ, Repine JD. Oxygen metabolites stimulate release of high molecular weight glycoconjugates by cell and organ cultures of rodent respiratory epithelium via an arachidonic acid-dependent mechanism. J Clin Invest. 1990;85:75\u201385.","journal-title":"J Clin Invest"},{"issue":"1","key":"1037_CR34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/0304-4165(86)90119-4","volume":"880","author":"N Houdret","year":"1986","unstructured":"Houdret N, Perini JM, Galabert C, Scharfman A, Humbert P, Lamblin G, Roussel P. The high lipid content of respiratory mucins in cystic fibrosis is related to infection. Biochim Biophys Acta. 1986;880(1):54\u201361.","journal-title":"Biochim Biophys Acta"},{"key":"1037_CR35","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1165\/ajrcmb.13.5.7576687","volume":"13","author":"KB Adler","year":"1995","unstructured":"Adler KB, Fisher BM, Li H, Choe NH, Wright DT. Hypersecretion of mucin in response to inflammatory mediators by guinea-pig tracheal epithelial cells in vitro is blocked by inhibition of nitric oxide synthase. Am J Respir Cell Mol Biol. 1995;13:526\u201330.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"43","key":"1037_CR36","doi-asserted-by":"publisher","first-page":"36510","DOI":"10.1074\/jbc.M507977200","volume":"280","author":"JM Lora","year":"2005","unstructured":"Lora JM, Zhang DM, Liao SM, Burwell T, King AM, Barker PA, et al. Tumor necrosis factor-alpha triggers mucus production in airway epithelium through an IkappaB kinase beta-dependent mechanism. J Biol Chem. 2005;280(43):36510\u20137.","journal-title":"J Biol Chem"},{"key":"1037_CR37","first-page":"1","volume-title":"Airway wall remodelling in asthma","author":"AJ James","year":"1997","unstructured":"James AJ. Relationship between airway wall thickness and airway hyperresponsiveness. In: Stewart AG, editor. Airway wall remodelling in asthma. L: CRC Press; 1997. p. 1\u201327."},{"key":"1037_CR38","first-page":"S46","volume":"54","author":"SH Phan","year":"1996","unstructured":"Phan SH. Role of the myofibroblast in pulmonary fibrosis. Kidney IntSuppl. 1996;54:S46\u20138.","journal-title":"Kidney IntSuppl"},{"issue":"2","key":"1037_CR39","first-page":"527","volume":"148","author":"HY Zhang","year":"1996","unstructured":"Zhang HY, Gharaee-Kermani M, Zhang K, Karmiol S, Phan SH. Lung fibroblast alpha-smooth muscle actin expression and contractile phenotype in bleomycin-induced pulmonary fibrosis. Am J Pathol. 1996;148(2):527\u201337.","journal-title":"Am J Pathol"},{"issue":"1","key":"1037_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/00063198-200301000-00005","volume":"9","author":"EA Kelly","year":"2003","unstructured":"Kelly EA, Jarjour NN. Role of matrix metalloproteinases in asthma. Curr Opin Pulm Med. 2003;9(1):28\u201333.","journal-title":"Curr Opin Pulm Med"},{"issue":"1","key":"1037_CR41","doi-asserted-by":"publisher","first-page":"11797","DOI":"10.1038\/s41598-017-12221-w","volume":"7","author":"IS Song","year":"2017","unstructured":"Song IS, Jeong YJ, Park JH, Shim S, Jang SW. Chebulinic acid inhibits smooth muscle cell migration by suppressing PDGF-R\u03b2 phosphorylation and inhibiting matrix metalloproteinase-2 expression. Sci Rep. 2017;7(1):11797.","journal-title":"Sci Rep"},{"issue":"2","key":"1037_CR42","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.yexcr.2015.06.020","volume":"336","author":"W Liu","year":"2015","unstructured":"Liu W, Kong H, Zeng X, Wang J, Wang Z, Yan X, Wang Y, Xie W, Wang H. Iptakalim inhibits PDGF-BB-induced human airway smooth muscle cells proliferation and migration. Exp Cell Res. 2015;336(2):204\u201310.","journal-title":"Exp Cell Res"},{"issue":"2","key":"1037_CR43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/08977190701398977","volume":"25","author":"SJ Kim","year":"2007","unstructured":"Kim SJ, Kim SY, Kwon CH, Kim YK. Differential effect of FGF and PDGF on cell proliferation and migration in osteoblastic cells. Growth Factors. 2007;25(2):77\u201386.","journal-title":"Growth Factors"},{"issue":"3","key":"1037_CR44","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S1386-6346(03)00112-8","volume":"26","author":"M Takahashi","year":"2003","unstructured":"Takahashi M, Matsui A, Inao M, Mochida S, Fujiwara K. ERK\/MAPK-dependent PI3K\/Akt phosphorylation through VEGFR-1 after VEGF stimulation in activated hepatic stellate cells. Hepatol Res. 2003;26(3):232\u20136.","journal-title":"Hepatol Res"},{"issue":"1","key":"1037_CR45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1465-9921-12-45","volume":"12","author":"D Wu","year":"2011","unstructured":"Wu D, Lee D, Sung YK. Prospect of vasoactive intestinal peptide therapy for COPD\/PAH and asthma: a review. Respir Res. 2011;12(1):45.","journal-title":"Respir Res"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01037-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-01037-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01037-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T12:37:10Z","timestamp":1725539830000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-01037-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,9]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1037"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-01037-2","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,9]]},"assertion":[{"value":"2 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were performed according to the protocols approved by Institutional Animal Care and Use Committee (IACUC) at Chonbuk National University, South Korea.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"D. W. was a former employee (1996\u20131999) and consultant of BI and has continued to collaborate with Boehringer Ingelheim. A. P. and H. D. are employees of Boehringer Ingelheim. This does not alter the authors' adherence to all the journal policies on sharing data and materials. Other co-authors: None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}